We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+28.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$1.01B
AUM Growth
-$202M
Cap. Flow
-$355M
Cap. Flow %
-35.04%
Top 10 Hldgs %
17.77%
Holding
972
New
385
Increased
62
Reduced
71
Closed
428

Sector Composition

Rank Sector Weight
1 Healthcare 32.37%
2 Technology 10.24%
3 Industrials 10.18%
4 Financials 8.13%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMC icon
276
Vulcan Materials
VMC
$36.3B
$817K 0.08%
+5,510
New +$786K
ZM icon
277
PUT
Zoom
ZM
$25.8B
$813K 0.08%
+2,300
New +$1.03M
DISH
278
DELISTED
DISH Network Corp.
DISH
$809K 0.08%
+25,000
New +$769K
KLRS
279
Kalaris Therapeutics
KLRS
$88.7M
$799K 0.08%
+865
New +$665K
DDMXU
280
DELISTED
DD3 Acquisition Corp. II Unit
DDMXU
$788K 0.08%
+75,000
New +$781K
REGN icon
281
Regeneron Pharmaceuticals
REGN
$68.8B
$772K 0.08%
1,598
+616
+63% +$333K
SOHU
282
Sohu.com
SOHU
$336M
$764K 0.08%
47,426
MRACU
283
DELISTED
Marquee Raine Acquisition Corp. Unit
MRACU
$760K 0.08%
+70,000
New +$747K
SPIR icon
284
Spire Global
SPIR
$425M
$759K 0.08%
+9,327
New +$736K
SAII
285
DELISTED
Software Acquisition Group Inc. II Class A Common Stock
SAII
$753K 0.07%
+75,000
New +$735K
ASTS icon
286
AST SpaceMobile
ASTS
$16.8B
$747K 0.07%
+55,000
New +$583K
PTCT icon
287
PTC Therapeutics
PTCT
$6.37B
$739K 0.07%
+12,000
New +$707K
KA
288
DELISTED
Kineta, Inc. Common Stock
KA
$739K 0.07%
+6,211
New +$944K
CYTK icon
289
Cytokinetics
CYTK
$11B
$738K 0.07%
35,500
-4,500
-11% -$82.2K
IACA.U
290
DELISTED
ION Acquisition Corp 1 Ltd. Units, each consisting of one Class A ordinary share and one-fifth of on
IACA.U
$733K 0.07%
+56,266
New +$618K
IBB icon
291
iShares Biotechnology ETF
IBB
$9.31B
$727K 0.07%
4,771
-8,742
-65% -$1.25M
PG icon
292
Procter & Gamble
PG
$343B
$715K 0.07%
+5,136
New +$718K
DMTK
293
DELISTED
DermTech, Inc. Common Stock
DMTK
$714K 0.07%
20,000
-254,870
-93% -$3.61M
BMRN icon
294
BioMarin Pharmaceuticals
BMRN
$11.5B
$710K 0.07%
+8,100
New +$642K
XP icon
295
XP
XP
$8.62B
$708K 0.07%
+17,500
New +$715K
NVAX icon
296
Novavax
NVAX
$1.23B
$707K 0.07%
+5,940
New +$631K
XBI icon
297
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$706K 0.07%
4,897
-15,676
-76% -$2.01M
APD icon
298
CALL
Air Products & Chemicals
APD
$66.3B
$683K 0.07%
+2,500
New +$704K
MDWT
299
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$676K 0.07%
+11,863
New +$685K
LYB icon
300
PUT
LyondellBasell Industries
LYB
$19.5B
$669K 0.07%
+7,300
New +$595K

Similar funds

Maven Securities's Q4 2020 Portfolio in Review

As of Q4 2020, Maven Securities held 972 positions worth $1.01B, down 17% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Maven Securities withdrew a net $355M in Q4 2020, closing 428 positions and reducing 71 holdings. Its most notable exit was Immunomedics Inc, an estimated $32.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Maven Securities opened a new position in Corelogic, Inc. worth $14.7M.

  • Maven Securities's largest Q4 2020 buy was Corelogic, Inc.: 189,483 shares worth $14.7M.
  • Maven Securities added most to AdaptHealth in Q4 2020, an estimated $14.9M increase.
  • Maven Securities's biggest Q4 2020 reduction was Triterras, Inc. Class A Ordinary Shares, cutting an estimated $15.2M.
  • Maven Securities fully exited Immunomedics Inc in Q4 2020, selling an estimated $32.8M.
  • Maven Securities's ten largest holdings make up 18% of its $1.01B portfolio in Q4 2020.
  • Maven Securities opened 385 new positions and closed 428 in Q4 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.01B.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.